Dexcom (DXCM) Other Accumulated Expenses (2011 - 2026)

Dexcom (DXCM) has 16 years of Other Accumulated Expenses data on file, last reported at $7.6 million in Q1 2026.

• Quarterly Other Accumulated Expenses fell 84.89% year-over-year to $7.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.6 million (down 84.89% YoY) and the FY2025 annual result came in at $7.7 million, down 79.25% from the prior year.
• Other Accumulated Expenses declined to $7.6 million in Q1 2026 per DXCM's latest filing, from $7.7 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $62.9 million in Q1 2022 and bottomed at $7.6 million in Q1 2026.
• The 5-year median for Other Accumulated Expenses is $42.0 million (2025), against an average of $40.5 million.
• The widest annual swing landed in 2022, when Other Accumulated Expenses surged 41.67%; it then tumbled 84.89% in 2026.
• Tracing DXCM's Other Accumulated Expenses over 5 years: stood at $39.7 million in 2022, then advanced by 2.02% to $40.5 million in 2023, then decreased by 8.4% to $37.1 million in 2024, then slumped by 79.25% to $7.7 million in 2025, then decreased by 1.3% to $7.6 million in 2026.
• Per Business Quant, the three latest DXCM Other Accumulated Expenses figures stand at $7.6 million (Q1 2026), $7.7 million (Q4 2025), and $42.0 million (Q3 2025).

Peer Comparison